SCHEMBL6137718

SCHEMBL6137718

O=C1Nc2c(F)cccc2C2CCCC12F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 5/20 0.52
NOS1 P29475 5/20 0.52
NOS2 P35228 5/20 0.52
PDE7A Q13946 1/20 0.37
PDK2 Q15119 1/20 0.35
PDK4 Q16654 1/20 0.35
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33
OPRL1 P41146 2/20 0.32
OPRM1 P35372 1/20 0.32
OPRD1 P41143 1/20 0.32
OPRK1 P41145 1/20 0.32
TP53 P04637 1/20 0.32
CHRNB2 P17787 1/20 0.32
CHRNA4 P43681 1/20 0.32
GAA P10253 1/20 0.32
ALDH1A1 P00352 1/20 0.32
SRD5A1 P18405 1/20 0.31
DDB1 Q16531 1/20 0.31
CRBN Q96SW2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137325 0.83 NOS3 (0.52) NOS3NOS1NOS2PDE7ACHRNB2
SCHEMBL6137634 0.78 NOS3 (0.48) NOS3NOS1NOS2OPRL1OPRM1
SCHEMBL6137403 0.69 NOS3 (1.00) NOS3NOS1NOS2HTR2CHTR2B
SCHEMBL7171102 0.69 NOS3 (0.59) NOS3NOS1NOS2GAA
SCHEMBL6137774 0.68 NOS3 (0.39) NOS3NOS1NOS2DDB1CRBN
SCHEMBL6137467 0.68 POLB (0.43) NOS3NOS1NOS2TP53CA12
SCHEMBL6137746 0.68 NOS3 (0.55) NOS3NOS1NOS2PDE7ATP53
SCHEMBL6137659 0.67 NOS3 (0.44) NOS3NOS1NOS2PDE7APDK2
SCHEMBL6137677 0.66 TDP2 (0.39) NOS3NOS1NOS2SRD5A1
SCHEMBL6137525 0.66 NOS3 (0.41) NOS3NOS1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1129077-B9 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-07-20 EP disclosed
EP-1129077-B1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-04-20 EP disclosed
US-6579883-B1 Nitrogen monoxide synthases; 4-amino-8-bromo-3a-fluoro-2,3,3a,9b-tetrahydro-1H-cyclopenta (c) quinoline; neurodegenerative, autoimmune, cardiovascular diseases SCHERING AKTIENGESELLSCHAFT (DE) 2003-06-17 US disclosed
EP-1129077-A1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2001-09-05 EP disclosed
WO-2000029381-A1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2000-05-25 WO disclosed